Clinical Evaluation of Terap C Vaccine Candidate in Combined Treatment with Interferon and Ribavirin in Patients with Hepatitis C

Conclusions: Vaccination with Terap C in patients with chronic HCV infection was safe and well tolerated.
Source: Current Therapeutic Research - Category: Drugs & Pharmacology Source Type: research